Minretumomab

Minretumomab (CC-49) is a murine monoclonal antibody against TAG-72 (tumor-associated glycoprotein 72) . Minretumomab is used in cancer and immunity research[1][2].

Product Specifications

CAS Number

[195189-17-4]

Product Name Alternative

CC-49

UNSPSC

12352203

Target

Mucin

Type

Inhibitory Antibodies

Related Pathways

Immunology/Inflammation

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/minretumomab.html

Purity

97.37

Solubility

10 mM in DMSO

Smiles

[Minretumomab]

Molecular Weight

(146.06 kDa)

References & Citations

[1]Graves SS, et al. Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy. Clin Cancer Res. 2003 Sep 1;9 (10 Pt 1) :3712-21.|[2]Sheikh N. Technology evaluation: CC49 humanized radioimmunoconjugates, National Cancer Institute. Curr Opin Mol Ther. 2003 Aug;5 (4) :428-32.